The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
in Israel and Europe for research on artificial intelligence
in Europe and #21 in the world for aerospace engineering*
companies founded by graduates and faculty in the last 10 years
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs Seen in BSF.org
Researchers at the Technion Faculty of Biology have identified potential new innovative genetic therapies for cancer and brain diseases.
The findings were supported by the Israel Science Foundation (ISF), the US-Israel Binational Science Foundation (BSF), NSF-BSF Molecular and Cellular Biosciences, and the National Institutes of Health (NIH) and were published in the peer-reviewed journal Nucleic Acids Research.
The study was conducted in collaboration with the research group of Professor Heather Hundley from Indiana University and was led by Ph.D student Berta Eliad, master’s student Noa Schneider, and their advisor, Associate Professor Ayelet Lamn.
by
www.bsf.org.il (opens in a new tab)
on
November 22, 2024
Technion researchers have identified potential new innovative genetic therapies for cancer and brain diseases.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Faculty / Biotech / Cancer / Healthy Aging / Intelligent Drugs / Neurological Diseases /
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Prof. Hossam Haick of the Technion – Israel Institute of Technology, one of Israel’s most successful scientists, is really a frustrated karate fighter. As a boy in Nazareth, he joined a karate class and seemed to have found his calling. “I was incredibly competitive,” he says. “I went from one achievement to the next.” But […]
The Nobel Assembly at Karolinska Institutet announced Monday that professors Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Medicine, with two of the three laureates having received the Technion-Israel Institute of Technology Harvey Prize. Prof. Deisseroth of the Howard Hughes Medical Institute and Stanford University, USA, and Prof. Hegemann […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.